z-logo
open-access-imgOpen Access
Efficacy and Safety of Zanubrutinib in IgA-secerning Lymphoplasmacytic Lymphoma
Author(s) -
Giulia Zamprogna,
Anna Maria Frustaci,
Marina Deodato,
Heather Allewelt,
Dirk Weber,
Claudia Rigamonti,
Alessandra Tedeschi
Publication year - 2022
Publication title -
journal of cancer science and clinical therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2637-5079
DOI - 10.26502/jcsct.5079151
Subject(s) - lymphoplasmacytic lymphoma , medicine , waldenstrom macroglobulinemia , lymphoma , ibrutinib , radiation therapy , chemotherapy , oncology , cancer research , chronic lymphocytic leukemia , leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here